Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?

To: tonyt who wrote (1237)	3/4/1998 11:01:00 AM
From: celeryroot.com	Read Replies (2) \| Respond to of 2173

415 2524700, you have to be a subscriber. He talked to company and said they were surprised with J&J move. They will be supported for next 6 months. 25% reduction of work force which is currently around 260. Trial results will be made public 4th quarter, MM said he advised them to wait before finding another partner.Said company was positive of good results and J&J claims their decision has nothing to do with technology.Thinks stock will quickly go back to 4-5.Thinks Amln will look back upon this as positive. I wonder if J&J isn't looking at AGN again??? Is anyone else having trouble with SI, it took me 15 min to pull your message.

To: tonyt who wrote (1237)	3/4/1998 3:52:00 PM
From: Rudy Saucillo	Read Replies (3) \| Respond to of 2173

<<< I called his 900# yesterday, he said to 'buy', for a 'quick' recovery, and that AMLN should be back above $5 by August. >>> Yeah, and if you believe that, Murphy's got just the newsletter for you! It doesn't take much intuition to realize that AMLN won't perform until it releases clearly positive Phase III data for Type I. Data from the Type I Euro trial to be released in 4thQ98 is, for all practical purposes, their last chance for pramlintide. Given the marginal data released last Aug., this is a coin toss. I don't mean to sound sarcastic; I'm just amazed (not surprised) at Murphy's comments. Rudy